Related Experiment Video
Updated: May 16, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
["Off label" use of some medicinal products. Part I]
Abstract:
The review is devoted to the complex drug administrating process and the process of making decisions, both affected by the country official regulations, the established guidelines for good clinical practice and last but not least--the knowledge and discretion of the individual physician prescribing a medicine. The publication gives emphasis on the "off label use"--the practice of prescribing pharmaceuticals for an unapproved by official drug institutions indications or in an unapproved age group, unapproved dose or unapproved form of administration. Numerous cases of widespread and even routine practice of "off label use" made for the benefit of the patients are presented. Details of current drug regulations in Bulgaria are provided. Examples of drug prescriptions are drawn for indications other than those specified in the marketing authorization certificate, showing the gap between the established practices, the professionals opinions and the regulators delayed reactions, influenced by the policies of the pharmaceutical industry.
Related Concept Videos
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Drug Classes and Categories
Drug Nomenclature
FDA Approved Drugs: Changes to Approved Drugs
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Drug Regulation
